ABEONA THERAPEUTICS INC. Proceeds from Issuance of Private Placement
ABEONA THERAPEUTICS INC. (ABEO) reported Proceeds from Issuance of Private Placement of $22.98 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2025-03-20
- ABEONA THERAPEUTICS INC. proceeds from issuance of private placement for the quarter ending 2023-12-31 was $1.00K.
- ABEONA THERAPEUTICS INC. proceeds from issuance of private placement for fiscal 2023 was $22.98M.
| Period end | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $22.98M 10-K · filed 2025-03-20 | |||
| 2023-09-30 | $22.98M 10-Q · filed 2024-11-14 | ||||
| 2015-07-31 | $15.50M 10-K · filed 2016-03-30 | ||||
| 2015-06-30 | $4.60M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |